MLND Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc is a part of the healthcare sector. Its core area of operation involves commercialization of new fertility treatments for women using its patented technology.

$1.52
As of 06/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/12/2012
Outstanding shares:  19,043,034
Average volume:  2,653,095
Market cap:   $29,135,842
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    60040X103
ISIN:        US60040X1037
Sedol:      BFN2XS6
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.48
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy